Amendment history : Erratum ( April 2004 ) New insights into atopic dermatitis

Atopic dermatitis is a chronic inflammatory skin disease associated with cutaneous hyperreactivity to environmental triggers and is often the first step in the atopic march that results in asthma and allergic rhinitis. The clinical phenotype that characterizes atopic dermatitis is the product of interactions between susceptibility genes, the environment, defective skin barrier function, and immunologic responses. This review summarizes recent progress in our understanding of the pathophysiology of atopic dermatitis and the implications for new management strategies.

[1]  T. Bieber,et al.  Evidence for a differential expression of the FcepsilonRIgamma chain in dendritic cells of atopic and nonatopic donors. , 2003, The Journal of clinical investigation.

[2]  Thomas Bieber,et al.  Evidence for a differential expression of the FcεRIγ chain in dendritic cells of atopic and nonatopic donors , 2003 .

[3]  R. Geha,et al.  IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. , 2003, The Journal of clinical investigation.

[4]  Santa Jeremy Ono,et al.  Chemokines: roles in leukocyte development, trafficking, and effector function. , 2003, The Journal of allergy and clinical immunology.

[5]  T. Beaty,et al.  Associations between total serum IgE levels and the 6 potentially functional variants within the genes IL4, IL13, and IL4RA in German children: the German Multicenter Atopy Study. , 2003, The Journal of allergy and clinical immunology.

[6]  M. Boguniewicz,et al.  Current management of atopic dermatitis and interruption of the atopic march. , 2003, The Journal of allergy and clinical immunology.

[7]  P. Elias,et al.  Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. , 2002, Journal of the American Academy of Dermatology.

[8]  K. Wolff,et al.  Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well tolerated. , 2002, The Journal of investigative dermatology.

[9]  T. Bieber,et al.  Immune mechanisms leading to atopic dermatitis. , 2003, The Journal of allergy and clinical immunology.

[10]  Tomas Ganz,et al.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis. , 2002, The New England journal of medicine.

[11]  T. Bieber,et al.  Allergic and nonallergic forms of atopic diseases. , 2003, The Journal of allergy and clinical immunology.

[12]  J. Travers,et al.  Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes 1 , 2003, The Journal of Immunology.

[13]  H. Hönigsmann,et al.  Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. , 2003, Journal of the American Academy of Dermatology.

[14]  R. Geha,et al.  Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. , 1999, The Journal of clinical investigation.

[15]  A. Burks,et al.  Effect of anti-IgE therapy in patients with peanut allergy. , 2003, The New England journal of medicine.

[16]  Q. Hamid,et al.  Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. , 1994, The Journal of clinical investigation.

[17]  R. Geha,et al.  Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. , 1998, The Journal of clinical investigation.

[18]  T. Kupper.  Immunologic targets in psoriasis. , 2003, The New England journal of medicine.

[19]  C. Akdis,et al.  T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  R. Damstra,et al.  Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study , 2003, BMJ : British Medical Journal.

[21]  J. Ortonne,et al.  Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. , 2002, The Journal of allergy and clinical immunology.

[22]  T. Bieber,et al.  Unraveling the mission of FcepsilonRI on antigen-presenting cells. , 2003, The Journal of allergy and clinical immunology.

[23]  S. Weiland,et al.  Association between polymorphisms in caspase recruitment domain containing protein 15 and allergy in two German populations. , 2003, The Journal of allergy and clinical immunology.

[24]  T. Bieber,et al.  Unraveling the mission of Fc?RI on antigen-presenting cells , 2003 .

[25]  C. Akdis,et al.  T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. , 2000, The Journal of clinical investigation.

[26]  A. Paller,et al.  Atopic dermatitis and the atopic march. , 2003, The Journal of allergy and clinical immunology.

[27]  J. Travers,et al.  Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. , 2003, The Journal of allergy and clinical immunology.

[28]  Q. Hamid,et al.  Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. , 2003, The Journal of allergy and clinical immunology.

[29]  T. Kupper,et al.  Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen. , 2003, The Journal of clinical investigation.

[30]  D. Leung,et al.  Atopic dermatitis: new insights and opportunities for therapeutic intervention. , 2000, The Journal of allergy and clinical immunology.

[31]  H. Sampson,et al.  Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. , 1993, The Journal of clinical investigation.

[32]  S. Salminen,et al.  Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial , 2003, The Lancet.

[33]  D. Leung.  Infection in atopic dermatitis , 2003, Current opinion in pediatrics.

[34]  加藤 敦.  Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population , 2003 .

[35]  T. Bieber,et al.  Atopic dermatitis , 2003, The Lancet.

[36]  Luting Xu,et al.  Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. , 2001, The Journal of investigative dermatology.